Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Retrospective Study of Inotuzumab Ozogamicin Treating Acute B-cell Lymphoblastic Leukemia

NCT07238907 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07238907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Retrospective Study of Inotuzumab Ozogamicin Treating Acute B-cell Lymphoblastic Leukemia
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2022
Completion date
July 31, 2026
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukaemia, acute lymphoblastic leukaemias (all), inotuzumab ozogamicin, venetoclax